Moderna MRNA has outperformed the market over the past 10 years by 32.49% on an annualized basis producing an average annual return of 43.18%. Currently, Moderna has a market capitalization of $70.24 billion.
Buying $100 In MRNA: If an investor had bought $100 of MRNA stock 10 years ago, it would be worth $3,619.70 today based on a price of $182.83 for MRNA at the time of writing.
Moderna's Performance Over Last 10 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.